Germline Variant Profiling of CHEK2 Sequencing Variants in Breast Cancer Patients

2024-11-1

Focal cortical dysplasia type IIIb associated with a KRAS-mutant ganglioglioma

2024-11-1

Brain abscesses, neutropenia, and B-ALL: multiple testing modalities required to confirm PDCD10 and ETV6 dual diagnoses

2024-11-1

Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance

2024-9-1

Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancer

2024-9-1

Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment

2024-9-1

Cancer treatments: Past, present, and future

2024-8-1

Editorial Board

2024-8-1

BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening

2024-8-1

Novel gene fusions in human oropharyngeal carcinoma

2024-8-1

SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1

2024-8-1

Whole Genome Joint Analysis Reveals ATM:c.1564_1565del Variant Segregating with Ataxia-Telangiectasia and Breast Cancer

2024-8-1

Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients

2024-8-1

A mechanistic insight into cancer progression mediated by Nucleoporins

2024-7-14

A complex t(15;22;17)(q22;q11.2;q21) variant of APL

2024-7-1

A Comparison of WHO-5 and ICC Classifications in a Series of Myeloid Neoplasms, Considerations for Hematopathologists and Molecular Pathologists

2024-6-22

Editorial Board

2024-6-1

CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer

2024-6-1

t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : a case report and literature review

2024-6-1

Successful treatment of the first adult case of ZMIZ1::ABL1-positive B cell lymphoblastic leukemia with dasatinib, chimeric antigen receptor T-cell therapy, and allogeneic hematopoietic stem cell transplantation

2024-6-1

LncRNA FOXD2-AS1 Promotes the Growth, Invasion and Migration of OSCC Cells by Regulating the MiR-185-5p/PLOD1/Akt/mTOR Pathway

2024-5-1

Clinical management of TP53 mosaic variants found on germline genetic testing

2024-4-1

Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature

2024-4-1

The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer

2024-4-1

Simultaneous occurrence of multiple myeloma and acute myeloid leukemia: Case report and literature review

2024-4-1

Editorial Board

2024-4-1

Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure

2024-4-1

Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression

2024-3-16

Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer.

2024-3-16

Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation

2024-3-7

Rare NUP98::PRRX1 fusion transcript in a therapy-related acute myeloid leukemia associated with del(7q) following chemotherapy for diffuse large B-cell lymphoma

2024-3-1

Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing

2024-1-1

Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report

2024-1-1

Editorial Board

2024-1-1

EML4-ALK Variant 3a/b as a mechanism of osimertinib resistance in a patient with EGFR L858R positive NSCLC

2024-1-1

Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature

2023-12-12

57. Curating variants of established clinical significance

2023-11-1

97. A rare case of low-hypodiploid acute lymphoblastic leukemia

2023-11-1

107. MyVariant.info: a gateway to integrated resource of variant annotations

2023-11-1

Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants

2023-11-1

9. Implementation survey of the ACMG/CGC standards for interpretation of acquired CNAs and CN-LOH in neoplastic disorders

2023-11-1

Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma

2023-11-1

71. Integrated genomic analysis of hepatocellular carcinoma using WES and aCGH

2023-11-1

Identification of a novel RSRC1-ALK (R6: A20) fusion using next-generation sequencing technique

2023-11-1

Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy

2023-11-1

39. Genomic microarray analysis reveals heterogeneity in high hyperdiploid B-cell acute lymphoblastic leukemia

2023-11-1

Corrigendum to “Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer” [Cancer Genetics Volumes 276–277, August 2023, Pages 48-59]

2023-11-1

92. The ClinGen Somatic CDWG supports somatic variant curation and interpretation through structured guidance and procedures

2023-11-1

Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma

2023-11-1

Pan-cancer genetic analysis of disulfidptosis-related gene set

2023-11-1